Asset Details
MbrlCatalogueTitleDetail
Do you wish to reserve the book?
Topical Antibiotic Therapy in the Ocular Environment: The Benefits of Using Moxifloxacin Eyedrops
by
Drago, Lorenzo
in
Antibiotics
/ Bacteria
/ Care and treatment
/ Control
/ Cornea
/ Defense mechanisms
/ DNA biosynthesis
/ DNA replication
/ Dosage and administration
/ Effectiveness
/ Eye
/ Eye infections
/ eyes
/ Fluoroquinolones
/ Fungi
/ Health care
/ health services
/ Homeostasis
/ humans
/ Microbiota
/ Microbiota (Symbiotic organisms)
/ Microorganisms
/ Moxifloxacin
/ ocular infections
/ ocular microbiota
/ Ophthalmology
/ Pathogens
/ patient compliance
/ prophylaxis
/ Proteins
/ Quinolones
/ Streptococcus infections
/ therapeutics
2024
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
You are currently in the queue to collect this book. You will be notified once it is your turn to collect the book.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Topical Antibiotic Therapy in the Ocular Environment: The Benefits of Using Moxifloxacin Eyedrops
by
Drago, Lorenzo
in
Antibiotics
/ Bacteria
/ Care and treatment
/ Control
/ Cornea
/ Defense mechanisms
/ DNA biosynthesis
/ DNA replication
/ Dosage and administration
/ Effectiveness
/ Eye
/ Eye infections
/ eyes
/ Fluoroquinolones
/ Fungi
/ Health care
/ health services
/ Homeostasis
/ humans
/ Microbiota
/ Microbiota (Symbiotic organisms)
/ Microorganisms
/ Moxifloxacin
/ ocular infections
/ ocular microbiota
/ Ophthalmology
/ Pathogens
/ patient compliance
/ prophylaxis
/ Proteins
/ Quinolones
/ Streptococcus infections
/ therapeutics
2024
Oops! Something went wrong.
While trying to remove the title from your shelf something went wrong :( Kindly try again later!
Do you wish to request the book?
Topical Antibiotic Therapy in the Ocular Environment: The Benefits of Using Moxifloxacin Eyedrops
by
Drago, Lorenzo
in
Antibiotics
/ Bacteria
/ Care and treatment
/ Control
/ Cornea
/ Defense mechanisms
/ DNA biosynthesis
/ DNA replication
/ Dosage and administration
/ Effectiveness
/ Eye
/ Eye infections
/ eyes
/ Fluoroquinolones
/ Fungi
/ Health care
/ health services
/ Homeostasis
/ humans
/ Microbiota
/ Microbiota (Symbiotic organisms)
/ Microorganisms
/ Moxifloxacin
/ ocular infections
/ ocular microbiota
/ Ophthalmology
/ Pathogens
/ patient compliance
/ prophylaxis
/ Proteins
/ Quinolones
/ Streptococcus infections
/ therapeutics
2024
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Topical Antibiotic Therapy in the Ocular Environment: The Benefits of Using Moxifloxacin Eyedrops
Journal Article
Topical Antibiotic Therapy in the Ocular Environment: The Benefits of Using Moxifloxacin Eyedrops
2024
Request Book From Autostore
and Choose the Collection Method
Overview
Moxifloxacin is a fourth-generation fluoroquinolone antibiotic available for ophthalmic use. It inhibits two enzymes involved in bacterial DNA synthesis, covering Gram-positive and Gram-negative pathogens. This spectrum allows for the formulation of self-preserving bottle solutions, while its interesting pharmacological profile is distinguished by efficacy at low tissue concentrations and by an infrequent dose regimen due to its long duration on ocular tissues. This enhances patient compliance, promoting its use in children. The human eye hosts several microorganisms; this collection is called the ocular microbiota, which protects the ocular surface, assuring homeostasis. When choosing an antibiotic, it is appropriate to consider its influence on microbiota. A short dose regimen is preferred to minimize the impact of the drug. Moxifloxacin eyedrops represent an effective and safe tool to manage and prevent ocular infections. As healthcare providers face the complexity of the ocular microbiota and microbial resistance daily, the informed use of moxifloxacin is necessary to preserve its efficacy in the future. In this regard, it is well known that moxifloxacin has a lower capacity to induce resistance (an optimal WPC and MPC) compared to other quinolones, but much still needs to be explored regarding the impact that fluoroquinolones could have on the ocular microbiota.
MBRLCatalogueRelatedBooks
Related Items
Related Items
We currently cannot retrieve any items related to this title. Kindly check back at a later time.
This website uses cookies to ensure you get the best experience on our website.